Tauntonbased health insurer WPA has been recognised as Britain's most innovative healthcare provider.
It scooped the accolade at the Laing & Buisson National Awards ceremony.
The prestigious award was for it Mycancerdrugs initiative, introduced in May to give the public access to expensive cancer drugs currently denied by the NHS in England.
It is the second successive year when WPA has been marked out as a leading UK healthcare innovator.
Mycancerdrugs is the first product of its kind anywhere in the world.
Julian Stainton, WPA's Chief Executive, says: "It is hard for the general public to comprehend, let alone a cancer sufferer, that the all-embracing NHS in England - unlike Scotland - denies patients these incredibly effective new drugs that have the ability to defeat cancer. Mycancerdrugs allows the public to access the most effective drugs available.It is ironic that it falls to a medical insurer to highlight these inequalities of care in the United Kingdom."